Abstract
The effects of 6 months of recombinant growth hormone (GH) treatment (0.5 IU kg-1 per week) on muscle size, strength and neural activation (EMG) was studied in eight adults with childhood onset GH deficiency (GHD). Before treatment, height, body mass (BM) and lean body mass (LBM) of the GHD subjects were significantly lower (P2 was found between the two groups. By contrast, LLV(M+B)/height3 was 82.0±19.0% that of the controls (P3 of the GHD patients after treatment was no longer significantly different from that of the controls. Quadriceps MVC increased by 9.8±12.0% (P
| Original language | English |
|---|---|
| Pages (from-to) | 527-537 |
| Number of pages | 11 |
| Journal | Clinical Physiology |
| Volume | 14 |
| Issue number | 5 |
| Publication status | Published - 1994 |
Fingerprint
Keywords
- GH deficiency
- Growth hormone
- Hypopituitarism
- Muscle cross-sectional area
- Muscle strength
ASJC Scopus subject areas
- Physiology
Cite this
Growth hormone (GH) treatment in GH-deficient adults : Effects on muscle size, strength and neural activation. / Sartorio, A.; Narici, M. V.
In: Clinical Physiology, Vol. 14, No. 5, 1994, p. 527-537.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Growth hormone (GH) treatment in GH-deficient adults
T2 - Effects on muscle size, strength and neural activation
AU - Sartorio, A.
AU - Narici, M. V.
PY - 1994
Y1 - 1994
N2 - The effects of 6 months of recombinant growth hormone (GH) treatment (0.5 IU kg-1 per week) on muscle size, strength and neural activation (EMG) was studied in eight adults with childhood onset GH deficiency (GHD). Before treatment, height, body mass (BM) and lean body mass (LBM) of the GHD subjects were significantly lower (P2 was found between the two groups. By contrast, LLV(M+B)/height3 was 82.0±19.0% that of the controls (P3 of the GHD patients after treatment was no longer significantly different from that of the controls. Quadriceps MVC increased by 9.8±12.0% (P
AB - The effects of 6 months of recombinant growth hormone (GH) treatment (0.5 IU kg-1 per week) on muscle size, strength and neural activation (EMG) was studied in eight adults with childhood onset GH deficiency (GHD). Before treatment, height, body mass (BM) and lean body mass (LBM) of the GHD subjects were significantly lower (P2 was found between the two groups. By contrast, LLV(M+B)/height3 was 82.0±19.0% that of the controls (P3 of the GHD patients after treatment was no longer significantly different from that of the controls. Quadriceps MVC increased by 9.8±12.0% (P
KW - GH deficiency
KW - Growth hormone
KW - Hypopituitarism
KW - Muscle cross-sectional area
KW - Muscle strength
UR - http://www.scopus.com/inward/record.url?scp=0027934869&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0027934869&partnerID=8YFLogxK
M3 - Article
C2 - 7820977
AN - SCOPUS:0027934869
VL - 14
SP - 527
EP - 537
JO - Clinical Physiology
JF - Clinical Physiology
SN - 0144-5979
IS - 5
ER -